In 2023, the worldwide infusion pump market boasted a total worth of $3.5 billion, marking a 3.1% uptick from the previous year when it stood at $3.4 billion. Projections indicate a continued growth trajectory throughout the forecast period, with a compound annual growth rate (CAGR) of 2.6%, ultimately reaching an estimated value of $4.2 billion. Notably, the current landscape of the global infusion pump market is predominantly influenced by the presence of two key players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 infusion pump companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global infusion pump market encompasses a range of categories, including large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps, and disposable ambulatory infusion pumps.
Senior patients, who may face challenges such as difficulty swallowing or the need for meticulous dosage management, derive substantial benefits from the precise and controlled administration of medications facilitated by infusion pumps. As the demographic of elderly individuals continues to expand, the significance of infusion pumps in meeting their specific medication requirements remains paramount and is expected to play an increasingly critical role in healthcare assistance.
Close on its heels, B. Braun secured the second position in the global infusion pump market for the year 2023. The company showcased a strong commitment to innovation, enhancing its infusion pump product lines with a particular emphasis on software improvements and space-efficient designs. B. Braun's Infusomat® volumetric pump, a globally recognized solution, has been available for a significant duration, and its latest iteration, the Infusomat® Space, deserves special mention. This compact and lightweight device is designed for stackability, optimizing space utilization and enabling the efficient placement of multiple pumps in limited areas.
The remainder of the market share was distributed among various competitors, each focusing on specific segments, with only a handful competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinctive advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as comprehensive one-stop solutions for healthcare facilities seeking to expand their pump capabilities.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 infusion pump companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global infusion pump market encompasses a range of categories, including large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps, and disposable ambulatory infusion pumps.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
COVID-19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL INFUSION PUMP MARKET INSIGHTS
The global infusion pump market is on an upward trajectory, driven by several factors. A significant contributor to this growth is the increasing elderly population, which has heightened the demand for infusion pumps in the realm of healthcare. As older individuals increasingly rely on complex medication regimens, infusion pumps have emerged as indispensable tools for ensuring the precise and safe delivery of pharmaceuticals.Senior patients, who may face challenges such as difficulty swallowing or the need for meticulous dosage management, derive substantial benefits from the precise and controlled administration of medications facilitated by infusion pumps. As the demographic of elderly individuals continues to expand, the significance of infusion pumps in meeting their specific medication requirements remains paramount and is expected to play an increasingly critical role in healthcare assistance.
GLOBAL INFUSION PUMP MARKET SHARE INSIGHTS
In the year 2023, Becton Dickinson (BD) emerged as the undisputed leader in the global infusion pump market. BD's strategic acquisition of CareFusion, coupled with its extensive IV therapy product line, firmly established its dominance in the IV infusion pump sector. Notably, BD's Alaris® product line distinguishes itself as a modular system encompassing vital modules such as the Alaris™ PC Unit, Alaris™ Pump Module, Alaris™ Syringe Module, Alaris™ PCA Module, Alaris™ Auto-ID Module, and Alaris™ EtCO2, providing comprehensive solutions tailored for diverse healthcare settings.Close on its heels, B. Braun secured the second position in the global infusion pump market for the year 2023. The company showcased a strong commitment to innovation, enhancing its infusion pump product lines with a particular emphasis on software improvements and space-efficient designs. B. Braun's Infusomat® volumetric pump, a globally recognized solution, has been available for a significant duration, and its latest iteration, the Infusomat® Space, deserves special mention. This compact and lightweight device is designed for stackability, optimizing space utilization and enabling the efficient placement of multiple pumps in limited areas.
The remainder of the market share was distributed among various competitors, each focusing on specific segments, with only a handful competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinctive advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as comprehensive one-stop solutions for healthcare facilities seeking to expand their pump capabilities.
MARKET SEGMENTATION SUMMARY
- Large-Volume Pump Market - Segmented By:
- Care Setting: Hospital, Non-Hospital
- Syringe Pump Market - Segmented By:
- Hospital, Non-Hospital
- Patient-Controlled Analgesia Pump Market - Segmented By:
- Care Setting: Hospital, Non-Hospital
- Electronic Ambulatory Pump Market
- Disposable Ambulatory Pump
Table of Contents
- Executive Summary
- Global Infusion Pump Market Overview
- Competitive Analysis
- Markets Included
- Regions Included
- Introduction
- Market Overview
- By Segment
- By Region
- Market Analysis and Forecast
- Total Infusion Pump Market
- Large-Volume Infusion Pump Market
- Hospital Large-Volume Infusion Pump Market
- Non-Hospital Large-Volume Infusion Pump Market
- Syringe Infusion Pump Market
- Hospital Syringe Infusion Pump Market
- Non-Hospital Syringe Infusion Pump Market
- Patient-Controlled Analgesia Infusion Pump Market
- Hospital Patient-Controlled Analgesia Infusion Pump Market
- Non-Hospital Patient-Controlled Analgesia Infusion Pump Market
- Electronic Ambulatory Infusion Pump Market
- Disposable Ambulatory Infusion Pump Market
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton Dickinson
- B. Braun
- Baxter
- ICU Medical
- Avanos Medical
- Fresenius Kabi
- Terumo
- Eitan Medical
- JMS
- Moog
- Micrel
- Nipro
- Ambu
- Applied Medical
- Arcomed
- CODAN
- Iradimed
- Ivenix
- Leventon
- Mindray
- Promed
- Samtronic
- Teleflex
- Walkmed Infusion
- Woo Young Medical
- Zyno Medical